#hemodialysis — Wednesday, June 03, 2026 (1 items)
| 0 | 💬 0 |
A multi-center, open-label, two-part study to investigate the effect of renal function and hemodialysis on the pharmacokinetics of the novel beta-lactamase inhibitor nacubactam.
(journals.asm.org)
|
Antimicrobial Agents and Chemotherapy 2026-06-03 | #pharmacokinetics #antibiotic #hemodialysis #renal |